Sex Differences in Tolerance to Delta-9-Tetrahydrocannabinol in Mice With Cisplatin-Evoked Chronic Neuropathic Pain.

Henderson-Redmond, Angela N; Crawford, LaTaijah C; Sepulveda, Diana E; Hale, David E; Lesperance, Julia J; Morgan, Daniel J

Henderson-Redmond, Angela N; Crawford, LaTaijah C; Sepulveda, Diana E; Hale, David E; Lesperance, Julia J; Morgan, Daniel J.

Afiliação

Henderson-Redmond AN; Department of Biomedical Sciences, Marshall University, Huntington, WV, United States.
Crawford LC; Department of Pharmacology, Penn State University College of Medicine, Hershey, PA, United States.
Sepulveda DE; Department of Anesthesiology and Perioperative Medicine, Penn State University College of Medicine, Hershey, PA, United States.
Hale DE; Department of Biomedical Sciences, Marshall University, Huntington, WV, United States.
Lesperance JJ; Department of Anesthesiology and Perioperative Medicine, Penn State University College of Medicine, Hershey, PA, United States.
Morgan DJ; Department of Pharmacology, Penn State University College of Medicine, Hershey, PA, United States.

Front Mol Biosci ; 8: 684115, 2021.

Article em En | MEDLINE | ID: mdl-34250019

Palavras-chave

cannabinoids; chronic pain; cisplatin; mice; sex-differences; tetrahydrocannabinol; tolerance

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Front Mol Biosci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos